Your browser doesn't support javascript.
loading
Doença de Alzheimer prodrômica. MCI, biomarcadores, prevenção e novas drogas / Alzheimer´s disease prodromal AD, mild cognitive impairment, prevention and new drugs
Sayeg, Norton.
  • Sayeg, Norton; Center for Clinical and Basic Research. São Paulo. BR
RBM rev. bras. med ; 72(5): 217-226, maio 2015.
Article in Portuguese | LILACS | ID: lil-749115
RESUMO
Este artigo discute dois novos conceitos doença de Alzheimer prodrômica (DAp) e deficiência cognitiva leve / mild cognitive impairment (MCI). Aborda a questão dos biomarcadores e da perspectiva futura de tratamentos e prevenção.
Subject(s)

Search on Google
Index: LILACS (Americas) Main subject: Pharmaceutical Preparations / Disease Prevention / Biomarkers, Pharmacological Language: Portuguese Journal: RBM rev. bras. med Journal subject: Medicine Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Center for Clinical and Basic Research/BR

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: LILACS (Americas) Main subject: Pharmaceutical Preparations / Disease Prevention / Biomarkers, Pharmacological Language: Portuguese Journal: RBM rev. bras. med Journal subject: Medicine Year: 2015 Type: Article Affiliation country: Brazil Institution/Affiliation country: Center for Clinical and Basic Research/BR